Moderna, Inc. (MRNA) › Operating Cash FlowModerna, Inc. (MRNA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: $66.73M2017: -$331.48M2018: -$330.87M2019: -$459.00M2020: $2.03B2021: $13.62B2022: $4.98B2023: -$3.12B2024: -$3.00B2025: -$1.87B-$1.87B2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$1.87B+37.6%2024-$3.00B+3.7%2023-$3.12B-162.6%2022$4.98B-63.4%2021$13.62B+571.9%2020$2.03B+541.6%2019-$459.00M-38.7%2018-$330.87M+0.2%2017-$331.48M-596.7%2016$66.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share